From Breakthroughs Blog: Access

 
UN Photo/Loey Felipe
Overheard at UNGA: 4 key takeaways on global health innovation

A “who’s who” of politicians, philanthropists, CEOs, and civil society leaders descended upon New York City this week for the annual United Nations General Assembly (UNGA). GHTC was there, serving as your eyes and ears on the ground. Here is what we heard and our top four takeaways on global health R&D.

Read More
WHO/L. Cipriani
WHA Roundup: Incremental steps forward on access and TB takes the limelight

What global health research advocates need to know about the 71st World Health Assembly (WHA).

Read More
Pan American Health Organization
What to watch at WHA 71

The 71st session of the World Health Assembly will see a number of debates that could impact global health R&D. Here is is what you need to know.

Read More
GHTC/Matt Robinson
WHO Executive Board approves actions on access to medicine and intellectual property

Last week’s World Health Organization (WHO) Executive Board meeting featured agenda items on access to medicines and intellectual property. We cover how debates on these items shook out:

Read More
PATH/Doune Porter
Research Roundup: CRISPR concerns, using innovation to cure malaria, and MSF's TB trial

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
WHO/L. Cipriani
WHA Roundup: a new WHO head, the demise of an R&D pooled fund, and the access debate rages on

The 70th World Health Assembly (WHA) winds to a close with key decisions that will shape the future of the World Health Organization (WHO) and the landscape for global health R&D.

Read More
PATH/Aaron Joel Santos
Research Roundup: Breaking down Zika and opportunities, challenges surrounding global immunization

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
GHTC/Matt Robinson
WHO Executive Board meeting closes with three shortlisted candidates to lead WHO and R&D issues added to WHA agenda

The 140th session of the World Health Organization (WHO) Executive Board closed last week with a shortlist of  three candidates for the WHO Director General position and progress on key global health R&D issues.

Read More
PATH/Gena Morgan
Why GHTC is joining the call for an essential diagnostics list

An essential diagnostic list list in a smart, cost-effective idea that could advance diagnostic R&D and access.

Read More
UN Photo/Joao Araujo Pinto
How did global health R&D fare at UNGA 71?

The 71st United Nations General Assembly (UNGA) concluded this week. Breakthroughs gives a synopsis of the key global health R&D issues discussed at the assembly and what actions were taken.

Read More
UN Photo/Loey Felipe
UNGA 2016: The world wakes up to AMR

The midtown Manhattan mayhem begins with the opening of the 71st United Nations General Assembly. GHTC preview the global health policy issues that will be discussed at this year's assembly.

Read More
Research Roundup: Vaccines for cholera and river blindness and an online platform for pooled procurement

Last week, an oral cholera vaccine received World Health Organization (WHO) prequalification, a process of regulatory review which paves the way for procurement by United Nations agencies and international organizations.

Read More
TPP: What does it mean for global health and what’s next?

After ten years of debate, on November 5, 2015, international negotiators released the final text of the largest regional trade agreement in history—the Trans Pacific Partnership (TPP).

Read More
The R&D agenda and how it addresses access to vaccines

In this guest post, Dr. Jayasree K. Iyer—Chief Scientific Officer at the Access to Medicine Foundation—writes about the findings from their newest study, which examines the current state of the vaccine pipeline and how large pharmaceutical companies are considering access to these products.

Access to Medicine Foundation
Read More